Position in NUVB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$548,742
-$689,332 QoQ
Shares Held
127,912
-7.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $374,315,342 across 207 Biotechnology names. NUVB ranks #95 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
70,804 | $31,616,818 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
80,930 | $26,074,836 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
152,645 | $25,800,057 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
374,931 | $24,231,790 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
23,567 | $18,208,806 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
1,805,184 | $17,004,833 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,738,062 | $15,659,938 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
708,527 | $13,858,788 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $548,742 | 127,912 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,238,074 | 138,178 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $547,085 | 147,861 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $300,356 | 154,029 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $157,229 | 89,335 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $275,701 | 103,647 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $208,506 | 91,051 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $308,579 | 105,678 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $310,823 | 85,391 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $119,724 | 79,288 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $106,245 | 79,288 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $142,718 | 79,288 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $110,044 | 66,292 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $82,152 | 42,788 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $145,239 | 64,839 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $210,078 | 64,839 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $471,690 | 89,675 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $490,450 | 57,700 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $253,976 | 25,551 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $158,214 | 16,994 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||